Locke Lord Team’s Federal Circuit Win on Behalf of Zydus Highlighted in IP Law 360

Michael Gaertner, Hugh Balsam, James Peterka, David Abramowitz, Wasim Bleibel and Timothy Peterson (all of Chicago) successfully represented clients Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited in securing a Federal Circuit decision affirming the district court’s ruling that Zydus’s generic version of Shire Development LLC’s ulcerative colitis drug Lialda does not infringe Shire’s U.S. Patent No. 6,773,720.

To read the complete article, click here (subscription may be required).